Comparison Overview
Clone Screening | Molecular Devices
Clone Screening | Molecular Devices
N/A
Last Update: 28/02/2026
Our solutions for antibody discovery and cell line development provide dedicated, scalable, and easy-to-use products for establishing clonal populations. The systems feature a selection of options and models to address your specific research including multiple imaging m...
Avantor
100 Matsonford Rd, Radnor Township, US
Last Update: 31/03/2026
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most impo...
Compliance Ranges Comparison
Clone Screening | Molecular Devices
Avantor
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Clone Screening | Molecular Devices in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Avantor in 2026.
Incident History - Clone Screening | Molecular Devices (X = Date, Y = Severity)
Clone Screening | Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Avantor (X = Date, Y = Severity)
Avantor cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Clone Screening | Molecular Devices
Avantor
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.